Hypotheses in non-inferiority trials [Power / Sample Size]

posted by mittyri  – Russia, 2015-06-16 23:52 (4022 d 15:14 ago) – Posting: # 14962
Views: 13,336

Hi Outlaw Torn

❝ What I'm getting at is this. When conducting a non-inferiority trial, are the roles of the type-I and type-II error rate reversed since the null hypothesis and the alternative hypothesis are reversed (Null Hypothesis H0 states non non-inferiority (i.e. inferiority) while Alternative Hypothesis H1 states non-inferiority between Test and Reference products)?


Let me cite Emmanuel Lesaffre:
"Demonstrating non-inferiority necessitates rejecting the null hypothesis (H0: ∆ > ∆NI) in favor of the alternative hypothesis (HA: ∆ < ∆NI) with an adapted classical statistical test (as for an equivalence test). A significant result (p < 0.025) means, in this case, that the experi­mental treatment is not (much) worse, i.e., non-inferior, to the control treatment, whereby the conclusion “non-inferior” depends on the chosen value for ∆NI."
I highly recommend you to read his great article (for me it's the best one). I think the relationships between equivalence, non-inferiority and superiority will be more clear.

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
171 visitors (0 registered, 171 guests [including 67 identified bots]).
Forum time: 15:06 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5